Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-026516·BB BIOTECH AG
Schedule 13G ownership disclosure
Black Diamond Therapeutics Inc
Common Stock · CUSIP: 09203E105
Event date: 2025-03-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BB Biotech AG
Shares: 2,733,547.00 · Class: 4.8%
- Biotech Growth N.V.
Shares: 2,733,547.00 · Class: 4.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-026516
- Form type
- SCHEDULE 13G/A
- Filer
- BB BIOTECH AG
- CIK
- CIK 924223
- Filed
- Mar 21, 2025
- Reporting period
- Mar 19, 2025
- Description
- Schedule 13G beneficial ownership